Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

    Recruiting

    2 1 1
    Denmark France Italy Spain
  • Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Recruiting

    3 1 1 1
    Austria Belgium Bulgaria Czechia Denmark Finland +12
  • Study on Patritumab Deruxtecan and Zirconium (89Zr) Patritumab Deruxtecan for Patients with Advanced EGFR Mutation Positive Lung Cancer

    Recruiting

    2 1 1
    Investigated diseases:
    The Netherlands
  • Study on Amivantamab, Lazertinib, and Bevacizumab for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer After Treatment Progression

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Italy The Netherlands Spain
  • Study of Osimertinib for Patients with EGFR-Mutated Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Lithuania Norway Sweden